Leiming Wu,
Yapeng Li,
Dianhong Zhang,
Zhen Huang,
Binbin Du,
Zheng Wang,
Lulu Yang and
Yanzhou Zhang*
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450052, Henan, China. E-mail: chizi965014mb@126.com; Tel: +86-37167967661
First published on 7th October 2022
Retraction of ‘LncRNA NEXN-AS1 attenuates proliferation and migration of vascular smooth muscle cells through sponging miR-33a/b’ by Leiming Wu et al., RSC Adv., 2019, 9, 27856–27864, https://doi.org/10.1039/C9RA06282C.
The western blots in Fig. 4F and 6D have been over-contrasted to the point where the background has almost been erased. In addition, there appear to be splice marks in the MMP-2 and β-actin panels in Fig. 7D, indicating that the images may have been manipulated. The authors are unable to provide verifiable raw data that could be used to validate the published images.
Given the significance of the concerns about the validity of the data, and the lack of raw data, the findings presented in this paper are not reliable.
The authors have not responded to any subsequent correspondence regarding the wording of the retraction notice.
Signed: Laura Fisher, Executive Editor, RSC Advances
Date: 18th August 2022
This journal is © The Royal Society of Chemistry 2022 |